ORINYライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (20 4月 2024 @ 04:49):

Stats
本日の出来高	19.00
平均出来高	159.00
時価総額	5.34B
EPS	$0 ( 2024-04-25 )
次の収益日	( $0 ) 2024-07-15
Last Dividend	$0.870 ( 2023-03-23 )
Next Dividend	$0 ( N/A )
P/E	21.34
ATR14	$0 (0.00%)

Orion Oyj 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Orion Oyj 財務諸表

Annual	2023
収益:	$1.19B
総利益:	$640.60M (53.77 %)
EPS:	$1.550

FY	2023
収益:	$1.19B
総利益:	$640.60M (53.77 %)
EPS:	$1.550

FY	2022
収益:	$1.34B
総利益:	$849.00M (63.33 %)
EPS:	$2.49

FY	2021
収益:	$1.04B
総利益:	$593.50M (57.01 %)
EPS:	$0.690

Financial Reports:

No articles found.

Orion Oyj Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0.870 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Orion Oyj Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.90 - Stable (18.06%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.739	2016-03-22
Last Dividend	$0.870	2023-03-23
Next Dividend	$0	N/A
Payout Date	2023-04-17
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	$7.52	--
Avg. Dividend % Per Year	0.00%	--
Score	3.46	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.90
Div. Directional Score	9.56	--

Next Divdend (Est)
(2024-10-07)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.46

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TRBK	Ex Dividend Junior	2023-08-03	Semi-Annually	0.00%
ITJTY	Ex Dividend Junior	2023-10-31	Annually	0.00%
BKKPF	Ex Dividend Junior	2023-09-06	Annually	0.00%
PUODY	Ex Dividend Knight	2023-06-21	Annually	0.00%
EPOKY	Ex Dividend Knight	2023-10-23	Semi-Annually	0.00%
VDMCY	Ex Dividend Knight	2023-06-22	Semi-Annually	0.00%
KSBI	Ex Dividend Knight	2023-07-28	Quarterly	0.00%
CGEMY	Ex Dividend Knight	2023-05-25	Annually	0.00%
SCGLY	Ex Dividend Junior	2023-05-25	Annually	0.00%
FSUGY	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.182	1.500	6.36	9.53	[0 - 0.5]
returnOnAssetsTTM	0.151	1.200	4.98	5.97	[0 - 0.3]
returnOnEquityTTM	0.269	1.500	8.12	10.00	[0.1 - 1]
payoutRatioTTM	1.037	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	3.12	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.749	0.800	4.42	3.53	[0.8 - 2.5]
cashRatioTTM	0.403	1.500	8.87	10.00	[0.2 - 2]
debtRatioTTM	0.136	-1.500	7.74	-10.00	[0 - 0.6]
interestCoverageTTM	77.13	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.848	2.00	9.72	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0164	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.220	-1.500	9.12	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.553	1.000	4.12	4.12	[0.2 - 0.8]
operatingProfitMarginTTM	0.201	1.000	7.98	7.98	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.609	1.000	7.73	7.73	[0.2 - 2]
assetTurnoverTTM	0.827	0.800	7.82	6.26	[0.5 - 2]
Total Score				13.21

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.59	1.000	9.03	0	[1 - 100]
returnOnEquityTTM	0.269	2.50	8.79	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0164	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	2.67	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.848	2.00	9.72	10.00	[0 - 30]
payoutRatioTTM	1.037	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-8.38	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.100	1.000	10.00	0	[0.1 - 0.5]
Total Score				5.90

Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.